Download PDF
Int J Angiol 2019; 28(03): 200-201
DOI: 10.1055/s-0038-1629919
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Longitudinal Stent Elongation of a Tapered Lesion during Percutaneous Coronary Intervention: A Case Report

Sen Matsumoto
1   Department of Cardiovascular Medicine, NTT West Japan Osaka Hospital, Osaka, Japan
,
Masayuki Sakakibara
1   Department of Cardiovascular Medicine, NTT West Japan Osaka Hospital, Osaka, Japan
,
Nagahiro Nishikawa
1   Department of Cardiovascular Medicine, NTT West Japan Osaka Hospital, Osaka, Japan
› Author Affiliations
Further Information

Publication History

Publication Date:
20 February 2018 (online)

    Permissions and Reprints

Abstract

The therapeutic strategy for percutaneous coronary intervention (PCI) of a tapered lesion is still being developed. Herein, we describe a 67-year-old man with stable angina who underwent elective PCI of a tapered lesion. The coronary angiogram showed diffuse, severe stenosis in the tapered left anterior descending artery. A third-generation sirolimus-eluting stent (2.5 × 24-mm Ultimaster, Terumo, Tokyo, Japan) was deployed, and the distal side was selected as the reference. Postdilatation with a balloon diameter 2.0 mm larger than the stent was needed because of the tapered lesion. We performed postdilatation from the distal side to the proximal side of the stent with a noncompliant balloon (4.5 × 8-mm Powered Lacrosse2, Goodman, Aichi, Japan). The final angiogram showed that the total stent length was 6 mm longer than the original length. Therefore, physicians should be aware of longitudinal stent elongation of a tapered lesion during PCI to ensure appropriate treatment.

Keywords

stent elongation - tapered lesion - coronary intervention - postdilatation
 

  • References

  • 1 Longo G, La Manna A, Capodanno D, Tamburino C. The Ultimaster® coronary stent system: state of the art. Minerva Cardioangiol 2015; 63 (03) 193-203
    PubMedGoogle Scholar
  • 2 Saito S, Valdes-Chavarri M, Richardt G. , et al; CENTURY II Investigators. A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial. Eur Heart J 2014; 35 (30) 2021-2031
    CrossrefPubMedGoogle Scholar
  • 3 Matsushita K, Arakawa K, Hibi K, Kimura K, Umemura S, Himeno H. Longitudinal stent deformation elongating to left main trunk. Cardiovasc Interv Ther 2014; 29 (03) 247-251
    CrossrefPubMedGoogle Scholar
  • 4 Rhee TM, Park KW, Lee JM. , et al. Predictors and long-term clinical outcome of longitudinal stent deformation: insights from pooled analysis of Korean multicenter drug-eluting stent cohort. Circ Cardiovasc Interv 2017; 10 (11) e005518
    PubMedGoogle Scholar
  • 5 Räber L, Jüni P, Löffel L. , et al. Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. J Am Coll Cardiol 2010; 55 (12) 1178-1188
    CrossrefPubMedGoogle Scholar
  • 6 Panoulas VF, Demir OM, Ruparelia N, Malik I. Longitudinal deformation of a third generation zotarolimus eluting stent: “The concertina returns!”. World J Cardiol 2017; 9 (01) 60-64
    CrossrefPubMedGoogle Scholar
  • 7 Premchand RK, Kumar YS. A report of successful procedural, clinical, and angiographic outcomes with a tapered stent of a patient in naturally tapered coronary vessel. J Clin Diagn Res 2017; 11 (01) OD06-OD07
    PubMedGoogle Scholar